KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $115.6 million.

  • Novavax's Accumulated Expenses fell 4714.23% to $115.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $115.6 million, marking a year-over-year decrease of 4714.23%. This contributed to the annual value of $211.2 million for FY2024, which is 4649.55% down from last year.
  • According to the latest figures from Q3 2025, Novavax's Accumulated Expenses is $115.6 million, which was down 4714.23% from $86.7 million recorded in Q2 2025.
  • In the past 5 years, Novavax's Accumulated Expenses registered a high of $673.7 million during Q4 2021, and its lowest value of $86.7 million during Q2 2025.
  • Its 5-year average for Accumulated Expenses is $344.6 million, with a median of $311.2 million in 2023.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first surged by 138551.58% in 2021, then crashed by 6526.57% in 2024.
  • Novavax's Accumulated Expenses (Quarter) stood at $673.7 million in 2021, then dropped by 12.26% to $591.2 million in 2022, then crashed by 33.24% to $394.7 million in 2023, then tumbled by 46.5% to $211.2 million in 2024, then tumbled by 45.26% to $115.6 million in 2025.
  • Its last three reported values are $115.6 million in Q3 2025, $86.7 million for Q2 2025, and $132.2 million during Q1 2025.